Feasability Study on the Use of Botulinum Toxin A in Primary Adductor Tendinopathies Refractory to Medical Treatment
Phase of Trial: Phase II
Latest Information Update: 21 May 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Pain
- Focus Therapeutic Use
- Acronyms PETRA
- 16 May 2019 Planned End Date changed from 1 Oct 2020 to 2 Aug 2020.
- 16 May 2019 Planned primary completion date changed from 1 Oct 2020 to 2 Aug 2020.
- 16 May 2019 Status changed from not yet recruiting to recruiting.